Drug recall · April 16, 2014
Demerol, meperidine HCL Inj. USP recall
Why: Labeling; Missing label; ampoules are missing the immediate container label
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.
- Lots / codes
Lot: 221303A, 1OCT2014
- Quantity
- 237,850 ampoules
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- March 25, 2014 · Voluntary: Firm initiated
- Classified
- April 8, 2014
- Reported
- April 16, 2014
- Ended
- December 18, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meperidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.